StonvexLoading…
StonvexStonvexStonvexCore line items from CSTL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $344.23M | $332.07M | $219.79M | $137.04M |
Operating Income | $-42.81M | $8.67M | $-67.98M | $-72.86M |
Net Income | $-24.16M | $18.25M | $-57.47M | $-67.14M |
EPS (Diluted) | $-0.83 | $0.62 | $-2.14 | $-2.58 |
Total Assets | $578.56M | $531.24M | $453.34M | $447.33M |
Total Liabilities | $107.68M | $75.40M | $62.07M | $48.18M |
Cash & Equivalents | $116.73M | $119.71M | $98.84M | $122.95M |
Free Cash Flow OCF − CapEx | $28.33M | $36.54M | $-19.25M | $-47.29M |
Shares Outstanding | 29.69M | 28.48M | 27.41M | 26.55M |